[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-341148-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-341148-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","molecular-targets-and-mechanisms-of-different-aberrant-alternative-splicing-in-metastatic-liver-cancer-minireviews","Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer - Minireviews","","Metastasis remains a major obstacle in treating malignant diseases, with the liver being a frequent and lethal destination for gastrointestinal cancers and other solid tumors. Alternative splicing is highlighted as a key driver of transcript and protein diversity, while splicing factor dysfunction and aberrant splice variants support tumor initiation, progression, aggressiveness, and drug resistance. This review summarizes normal splicing and its alterations in metastatic liver cancer, focusing on splicing factor changes, abnormal splicing, and hypoxia-associated contributions during metastasis.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/molecular-targets-and-mechanisms-of-different-aberrant-alternative-splicing-in-metastatic-liver-cancer-minireviews/341148/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/molecular-targets-and-mechanisms-of-different-aberrant-alternative-splicing-in-metastatic-liver-cancer-minireviews/341148.png","ImageObject",300,407,{"name":42,"@type":43},"Aurora","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-11","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem does the review focus on in metastatic disease?","Question",{"text":63,"@type":64},"The review focuses on how metastatic liver cancer is driven by mechanisms that influence tumor behavior. It emphasizes alternative splicing as a major molecular contributor to metastasis-related changes.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does alternative splicing relate to metastatic liver cancer?",{"text":68,"@type":64},"Alternative splicing generates diverse RNA transcripts and protein subtypes, potentially expanding target space. The review links abnormal alternative splicing to cancer occurrence, progression, aggressiveness, and drug resistance.",{"name":70,"@type":61,"acceptedAnswer":71},"Which aspects does the review cover regarding splicing changes?",{"text":72,"@type":64},"It summarizes normal splicing and details alterations seen in metastatic liver cancer. It covers splicing factor changes, aberrant splicing events, and the role of hypoxia in shaping these changes during metastasis.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},341148,1790395747,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":123,"language":139,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":12,"update_tm":143,"read_time":144,"preview_page_count":33,"preview_urls":145},4810365810221,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","| W | J | C | O | World Journal of\u003Cbr>Clinical Oncology |\n| --- | --- | --- | --- | --- |\n\nSubmit a Manuscript: [https://www.f6publishing.com](https://www.f6publishing.com) World J Clin Oncol 2024 April 24; 15(4): 531-539  \nDOI: 10.5306/wjco.v15.i4.531 ISSN 2218-4333 (online)  \nMINIREVIEWS  \nMolecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer  \nDe-Yi Geng, Qing-Shan Chen, Wan-Xian Chen, Lin-Sa Zhou, Xiao-Sha Han, Qi-Hu Xie, Geng-Hong Guo, XueFen Chen, Jia-Sheng Chen, Xiao-Ping Zhong  \nSpecialty type: Oncology  \nProvenance and peer review:  \nInvited article; Externally peer reviewed.  \nPeer-review model: Single blind  \nPeer-review report’s scientific quality classification  \nGrade A (Excellent): 0  \nGrade B (Very good): 0  \nGrade C (Good): C  \nGrade D (Fair): 0  \nGrade E (Poor): 0  \nP-Reviewer: Yoshinaga K, Japan  \nReceived: December 27, 2023  \nPeer-review started: December 27, 2023  \nFirst decision: January 15, 2024  \nRevised: January 29, 2024  \nAccepted: March 7, 2024  \nArticle in press: March 7, 2024  \nPublished online: April 24, 2024  \nDe-Yi Geng, Qing-Shan Chen, Wan-Xian Chen, Lin-Sa Zhou, Xiao-Sha Han, Qi-Hu Xie, Geng-Hong Guo, Xue-Fen Chen, Jia-Sheng Chen, Xiao-Ping Zhong, Department of Plastic and Burns Surgery, The Second Affiliated Hospital of Shantou University Medical College, Shantou 515000, Guangdong Province, China  \nDe-Yi Geng, Qing-Shan Chen, Wan-Xian Chen, Lin-Sa Zhou, Xiao-Sha Han, Qi-Hu Xie, Geng-Hong Guo, Xue-Fen Chen, Jia-Sheng Chen, Xiao-Ping Zhong, Plastic Surgery Research Institute, Ear Deformities Treatment Center and Cleft Lip and Palate Treatment Center of Shantou University Medical College, Shantou 515000, Guangdong Province, China  \nCorresponding author: Xiao-Ping Zhong, PhD, Professor, Department of Plastic and Burns Surgery, The Second Affiliated Hospital of Shantou University Medical College, Dongxia North Road, Shantou 515000, Guangdong Province, [China.](China. zhongxiaoping@stu.edu.cn)[ zhongxiaoping@stu.edu.cn](China. zhongxiaoping@stu.edu.cn)  \nAbstract  \nMetastasis remains a major challenge in the successful management of malignant diseases. The liver is a major site of metastatic disease and a leading cause of death from gastrointestinal malignancies such as colon, stomach, and pancreatic cancers, as well as melanoma, breast cancer, and sarcoma. As an important factor that influences the development of metastatic liver cancer, alternative splicing drives the diversity of RNA transcripts and protein subtypes, which may provide potential to broaden the target space. In particular, the dysfunction of splicing factors and abnormal expression of splicing variants are associated with the occurrence, progression, aggressiveness, and drug resistance of cancers caused by the selective splicing of specific genes. This review is the first to provide a detailed summary of the normal splicing process and alterations that occur during metastatic liver cancer. It will cover the role of alternative splicing in the mechanisms of metastatic liver cancer by examining splicing factor changes, abnormal splicing, and the contribution of hypoxia to these changes during metastasis.  \nKey Words: Alternative splicing; Carcinoma; Hepatocellular; Metastasic; Liver neoplasms; Prognosis  \n©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.  \n WJCO  [https://www.wjgnet.com](https://www.wjgnet.com) 531 April 24, 2024  Volume 15  Issue 4   \nGeng DY et al. AS’s targets and mechanisms in MLC  \nCore Tip: Metastatic liver cancer refers to tumors formed outside the liver that metastasize to the liver and colonize it. Abnormal alternative splicing is a molecular characteristic unique to almost all tumor types. Most tumors exhibit a wide range of splicing abnormalities compared to the surrounding healthy tissues. This review is the first to provide a detailed summary of the normal splicing process and alterations that occur during metastatic ","cbCaipn31kS2zCDL","https://ap.wps.com/l/cbCaipn31kS2zCDL","pdf",1703989,"English","# Core Tip\n# Introduction","[{\"question\":\"What problem does the review focus on in metastatic disease?\",\"answer\":\"The review focuses on how metastatic liver cancer is driven by mechanisms that influence tumor behavior. It emphasizes alternative splicing as a major molecular contributor to metastasis-related changes.\"},{\"question\":\"How does alternative splicing relate to metastatic liver cancer?\",\"answer\":\"Alternative splicing generates diverse RNA transcripts and protein subtypes, potentially expanding target space. The review links abnormal alternative splicing to cancer occurrence, progression, aggressiveness, and drug resistance.\"},{\"question\":\"Which aspects does the review cover regarding splicing changes?\",\"answer\":\"It summarizes normal splicing and details alterations seen in metastatic liver cancer. It covers splicing factor changes, aberrant splicing events, and the role of hypoxia in shaping these changes during metastasis.\"}]","Molecular targets and mechanisms of different aberrant alternative splicing in metastatic liver cancer - Minireviews | PDF",1790040559,25,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c12f326cedf88d4798a4cbe34f9af7e7.webp",983,1390,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/c018711e7d71e97784d1735b5fd0618f.webp",982,1389,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1946254779c8cf4e211108068fe62a5d.webp",981,1387,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cfc79e71d9763ebc7277d4d0078ebf07.webp",980,1386]